Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
    • Clinic Portal
      • +0034963905310
    • Request Information
    • +34 96 390 53 10
    InternationalInternational
    • Country/Region
    • We guide you
      • Fertility
        • What to do if…
      • Prevent Inherited Diseases
        • Carrier Genetic Test
      • Worry-free Pregnancy
        • NACE
        • Prenatal Diagnostics
        • Newborn Health
    • Reproductive Health
      • Specialists
        • ALICE
        • EMMA
        • ERA
        • EndomeTRIO
        • EMBRACE
        • CGT
        • NACE
        • Zenit
        • PGT-A
        • PGT-M
        • POC
        • SAT
        • Newborn Screening
      • Patients
        • ALICE
        • EMMA
        • ERA
        • EndomeTRIO
        • EMBRACE
        • CGT
        • NACE
        • Zenit
        • PGT-A
        • PGT-M
        • SAT
        • POC
    • Diagnostics
    • About us
      • Igenomix Research
      • About Igenomix
    • Academy
    • Blog
        Genomics Precision Diagnostic > Ear, Nose, Throat Precision Panel > Syndromic and Nonsyndromic Deafness Panel

        Syndromic and Nonsyndromic Deafness  Precision Panel

        Hearing loss can be defined as conductive or sensorineural. Conductive hearing loss occurs due to dysfunction of the outer or middle ear, which prevents transmission of sound waves from reaching the inner ear.
        Overview
        Indication
        Clinical Utility
        Genes & Diseases
        Methodology
        References

        Overview

        • Hearing loss can be defined as conductive or sensorineural. Conductive hearing loss occurs due to dysfunction of the outer or middle ear, which prevents transmission of sound waves from reaching the inner ear. Sensorineural hearing loss, on the other hand, is the result of inner ear or auditory nerve dysfunction preventing neuronal transmission to the brain. In developed countries, approximately 1/1,000 children have severe or profound hearing loss at birth or during childhood. In most cases, hearing loss is a multifactorial disorder caused by genetic and environmental factors.  Clinically, it has many different presentations, from mild to profound, including low and high-pitch patterns. Non-syndromic forms are responsible for about 70% of the cases of hereditary etiology and syndromic cases represent 30% of them. Among the patterns of inheritance, autosomal recessive remains the most common form of inheritance, although it can be autosomal dominant, X-linked or mitochondrial.   

        • The Igenomix Syndromic and Nonsyndromic Deafness Precision Panel can be used to make an accurate and directed diagnosis as well as a differential diagnosis of hearing loss ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

        Indication

        • The Igenomix Syndromic and Nonsyndromic Deafness Precision Panel  is indicated for those patients with a clinical suspicion or diagnosis with or without the following manifestations: 
          • Difficulty understanding words  
          • Muffling of speech and other sounds 
          • Trouble hearing consonants 
          • Needing to turn up the volume of the television or radio 
          • Associated syndromic features at birth: cardiac findings, renal findings, neurologic abnormalities, skeletal examination findings, craniofacial abnormalities etc 
          • Withdrawal from conversations 
          • Avoidance from social settings 

        Clinical Utility

        The clinical utility of this panel is: 

        • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
        • Early initiation of treatment with a multidisciplinary team in the form surgical care of external and middle ear deformities, cochlear implantation and medical care for treatment of middle ear disease, amplification and assistive listening devices.    
        • Early implementation of speech and language therapy.  
        • Risk assessment and genetic counselling of asymptomatic family members due to the autosomal dominant mode of inheritance.
        • Improvement of delineation of genotype-phenotype correlation. 

        Genes & Diseases

        Methodology

        References

        See scientific referrals

        Eisen MD, Ryugo DK. Hearing molecules: contributions from genetic deafness. Cell Mol Life Sci. 2007 Mar. 64(5):566-80 

        Morzaria, S., Westerberg, B., & Kozak, F. (2004). Systematic review of the etiology of bilateral sensorineural hearing loss in children. International Journal Of Pediatric Otorhinolaryngology, 68(9), 1193-1198. doi: 10.1016/j.ijporl.2004.04.013 

        Piatto, V. B., Nascimento, E. C., Alexandrino, F., Oliveira, C. A., Lopes, A. C., Sartorato, E. L., & Maniglia, J. V. (2005). Molecular genetics of non-syndromic deafness. Brazilian journal of otorhinolaryngology, 71(2), 216–223. https://doi.org/10.1016/s1808-8694(15)31313-6 

        Shaukat, S., Fatima, Z., Zehra, U., & Waqar, A. B. (2003). Syndromic and non-syndromic deafness, molecular aspects of Pendred syndrome and its reported mutations. Journal of Ayub Medical College, Abbottabad : JAMC, 15(3), 59–64. 

        Petersen, M. B., & Willems, P. J. (2006). Non-syndromic, autosomal-recessive deafness. Clinical genetics, 69(5), 371–392. https://doi.org/10.1111/j.1399-0004.2006.00613.x 

        Petersen M. B. (2002). Non-syndromic autosomal-dominant deafness. Clinical genetics, 62(1), 1–13. https://doi.org/10.1034/j.1399-0004.2002.620101.x 

        Ding, Y., Leng, J., Fan, F., Xia, B., & Xu, P. (2013). The Role of Mitochondrial DNA Mutations in Hearing Loss. Biochemical Genetics, 51(7-8), 588-602. doi: 10.1007/s10528-013-9589-6 

        descargar

        Detail description

        Download

        Request Information


        WE GUIDE YOU

        Fertility
        Inherited diseases prevention
        Healthy pregnancy

        To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

        OUR SERVICES

        Genetic solutions
        For patients
        How to send a sample?
        User manual

        ABOUT US

        About Igenomix
        Contact
        Quality
        Complaints
        Work with us

        FOLLOW IGENOMIX

          + 96 390 53 10
          Write us
        • Argentina
        • Brazil
        • Canada
        • Chile
        • Colombia
        • Europe
        • France
        • Germany
        • India
        • Italy
        • Japan
        • Korea
        • Mexico
        • Perú
        • Russia
        • Spain
        • Taiwan
        • The Middle East
        • Turkey
        • United Kingdom
        • United States
        • Vietnam
        Country/Region

        [2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

        Request Information


        • We guide you
          • Fertility
            • What to do if…
          • Prevent Inherited Diseases
            • Carrier Genetic Test
          • Worry-free Pregnancy
            • NACE
            • Prenatal Diagnostics
            • Newborn Health
        • Reproductive Health
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • Zenit
            • PGT-A
            • PGT-M
            • POC
            • SAT
            • Newborn Screening
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • Zenit
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • Diagnostics
        • About us
          • Igenomix Research
          • About Igenomix
        • Academy
        • Blog
        • Country/Region
        • +34 96 390 53 10
        • Clinic Portal
        • Request Information

        We are using cookies to give you the best experience on our website.

        You can find out more about which cookies we are using or switch them off in settings.

        International
        Powered by  GDPR Cookie Compliance
        Privacy Overview

        This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

        Strictly Necessary Cookies

        Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

        If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

        3rd Party Cookies

        This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

        Keeping this cookie enabled helps us to improve our website.

        Please enable Strictly Necessary Cookies first so that we can save your preferences!

        Cookie Policy

        More information about our Cookie Policy